awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55429844-0DA665B1-79DE-496E-A775-35B54FBF16CC
Q55429844-0DA665B1-79DE-496E-A775-35B54FBF16CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55429844-0DA665B1-79DE-496E-A775-35B54FBF16CC
Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.
P2860
Q55429844-0DA665B1-79DE-496E-A775-35B54FBF16CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55429844-0DA665B1-79DE-496E-A775-35B54FBF16CC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b45e94a813a20fde73a8fd8006532127b40e6e6
P2860
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study.